Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Other financing activities (2023 - 2026)

Compass Therapeutics' Other financing activities history spans 4 years, with the latest figure at -$489000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities rose 40.0% to -$489000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $9.0 million, a 6691.18% increase, with the full-year FY2025 number at $8.6 million, up 1490.79% from a year prior.
  • Other financing activities hit -$489000.0 in Q1 2026 for Compass Therapeutics, down from $8.6 million in the prior quarter.
  • Over the last five years, Other financing activities for CMPX hit a ceiling of $8.6 million in Q3 2025 and a floor of -$815000.0 in Q1 2025.
  • Historically, Other financing activities has averaged $937555.6 across 4 years, with a median of -$2000.0 in 2024.
  • The widest YoY moves for Other financing activities: up 431800.0% in 2025, down 499.26% in 2025.
  • Tracing CMPX's Other financing activities over 4 years: stood at -$254000.0 in 2023, then skyrocketed by 99.21% to -$2000.0 in 2024, then surged by 432000.0% to $8.6 million in 2025, then crashed by 105.66% to -$489000.0 in 2026.
  • Business Quant data shows Other financing activities for CMPX at -$489000.0 in Q1 2026, $8.6 million in Q3 2025, and $815000.0 in Q2 2025.